AEVI GENOMIC Balance Sheet - Quarterly (NASDAQ:GNMX)

Add to My Stocks
$1.2 $0.06 (5.26%) GNMX stock closing price Jun 22, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like AEVI GENOMIC, and helps in stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the AEVI GENOMIC stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing AEVI GENOMIC revenue AEVI GENOMIC operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The AEVI GENOMIC balance sheet for 2018 Q1 shows cash on hand of $26.52M. The company has a debt to equity ratio of .

View and download AEVI GENOMIC quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets---1.07M---1.09M--
Total Current Assets
Property Plant & Equipment-----1.8M---1.58M
Accumulated Depreciation-----1.42M---1.15M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable1.68M-3.48M1.88M2.8M---1.34M1.32M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses3.05M3.19M3.37M3.03M2.65M5.44M4.87M3.42M2.21M2.58M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus246.37M245.59M217.9M217.03M216.25M215M214.38M212.35M190.87M188.47M
Retained Earnings-223.68M-214.97M-207.81M-199.21M-191.18M-180.03M-171.55M-160.98M-149.27M-138.13M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity22.69M30.62M10.09M17.82M25.08M34.97M42.83M51.37M41.6M50.35M
Total Liabilities & Shareholders Equity27.43M34.76M16.94M22.74M30.53M40.56M48.33M55.3M45.16M54.25M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at AEVI GENOMIC historical stock prices and the current AEVI GENOMIC stock price can tell you how the stock price has moved, whereas the AEVI GENOMIC PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like AEVI GENOMIC owns and has monetary significance. GNMX assets decreased from $34.76M in 2017 Q4 to $27.43M in 2018 Q1. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case AEVI GENOMIC's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for GNMX stock stand at $4.73M.

AEVI GENOMIC Balance Sheet - Key Ratios